Danae
M
Hamouda,
MD
419.383.6644; Fax: 419.383.3339
Internal Medicine and Medical Oncology
Lung Cancer, Breast Cancer, Genetics; somatic and germline mutations
Research Interests: Precision Oncology, Hereditary Cancer Syndromes
Details
Firas
Petros,
MD, FACS
UTMC: 419.383.6644, Regency: 419.383.2464
American Board of Urology
Urologic Cancers including Prostate, Kidney and Adrenal, Upper Urinary Tract Cancers including Renal Pelvis and Ureteral Cancers, Bladder and Urethral Cancers, Testicular and Penile Cancers.
Open and Minimally Invasive Surgical Procedures including Endoscopy, Laparoscopy and Robotics.
Active Surveillance Programs for low risk Prostate Cancer and Small Renal Masses and Treatment of Urologic Diseases.
My primary research focuses on two disease entities Upper Tract Urothelial Carcinoma (UTUC) and Renal Cell Carcinoma (RCC). Specifically, translational research involving genomic profiling of UTUC and gene expression analysis of same-patient metachronous UTUC and bladder cancer. Furthermore, other areas of research include clinical research in UTUC and RCC studying disease stratification, surgical outcomes and complications.
Details
Roland
T.
Skeel,
MD
419.383.6644 Fax: 419.383.2924
Internal Medicine; Medical Oncology
Lung Cancer, Breast Cancer, Urologic Cancers, and Melanoma
Details
Divya
Vijendra,
MD
419.383.6644
Oncology
Breast
Gastrointestinal
Genitourinary
Lung
Neuro
Geriatric
Details
James
C.
Willey,
MD
DCC: 419.383.6644
Internal Medicine; Pulmonary and Critical Care Medicine
Clinical Interests: Lung Cancer; COPD; Precision Medicine
Research Interests: Lung Cancer; Molecular Diagnostic Testing; Precision Medicine
Details